Jin Geun-woo is the Chief Executive Officer of Hyundai Bioscience.
He was born on October 27, 1980.
He graduated from the Department of Chemistry at Seoul National University and received both his master’s and doctoral degrees in biochemistry from the graduate school of the same university.
He conducted research on anticancer drug delivery systems at the Fels Institute for Cancer Research at Temple University in the United States and at Samyang Biopharm.
After serving as a senior researcher at CNPharm, he joined Hyundai Bioscience as head of the research institute.
In March 2025, he was appointed CEO of Hyundai Bioscience. Since 2025, he has also served as co-CEO of Hyundai ADM Bio.
He is an expert in drug delivery systems. Coming from a research background, he values decision-making based on scientific evidence.
He faces challenges such as achieving clinical success, securing global approvals, strengthening financial stability, and responding to international regulations.
#HyundaiBioscience #JinGeunwoo #CEO #biopharmaceuticals #drugdelivery #anticancer #globalapproval #clinicalresearch #financialstability #biotech